Xiaoying Yu's Colleagues at Amador Bioscience
Patrick Hu
Chief Executive Officer and Chief Medical Officer of Clinical Research Business Unit (CRBU)
Xiaoying Yu's Contact Details
N/A
Ann Arbor,Michigan,United States
Amador Bioscience
Xiaoying Yu's Company Details
Amador Bioscience is a Translational & Clinical Pharmacology CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to leading biopharmaceutical companies in China, USA and EU. Amador is committed to facilitating innovative drug development from discovery to clinical development and global regulatory fillings. Since its inception in 2018, Amador Bioscience has actively supported 80+ clinical projects, multiple IND and 6 CTD filings in USA and China. Our clients range from cutting-edge biotech startups to industry-leading multinationals.